Clinical trials can sometimes change, pause or stop earlier than planned. Find out why this might happen, how families may hear updates, and where to turn for information and support.
Understanding trial changes and what happens next:
Taking part in a clinical trial can involve hope, commitment and uncertainty for the whole family. Understanding what might happen if a trial changes, pauses or stops early can help families feel more prepared.
Why might a trial pause or stop early?
Clinical trials may be paused or stopped for different reasons. These can include concerns about safety, findings suggesting a treatment is unlikely to deliver the benefit being studied, or practical, funding or business decisions.
A pause does not necessarily mean that a trial will end permanently, and a trial stopping does not automatically mean the treatment was unsafe. The reasons and implications need to be understood for each individual trial.
How and when might families hear news?
There may be uncertainty about when an update will be available and how much information it will contain. An initial announcement may come before the full results have been analysed, so some questions may take longer to answer.
For publicly listed companies, rules about sharing information that could affect their share price can influence the timing and way announcements are made. This may mean that families see news, whether encouraging or disappointing, through a public announcement, news report or social media before receiving a direct update.
We recognise how difficult this can be, especially for families taking part. Families deserve clear, timely and compassionate communication from the organisations running trials and their clinical teams. FAST UK is advocating for better communication about trial participation, updates and outcomes, and we hope to see positive changes in this area.
What happens if our family is taking part?
Any questions about your trial should be directed to the trial’s investigation team in the first instance. They should explain what any change means for you or your child, including arrangements for treatment, appointments, safety monitoring and follow-up care. Access to the trial treatment after a study ends is not guaranteed; your team can explain the arrangements for your particular trial.
Useful questions to ask include:
• Why has the trial been paused or stopped?
• What does this mean for treatment and upcoming appointments?
• Will any follow-up visits or safety checks be needed?
• Who should we contact with questions or concerns?
• When and how should we expect the next update?
If you hear news online and are unsure what it means for your family, contact your trial team. Do not change any treatment or care arrangements without speaking to them.
How FAST UK will support families
FAST UK will do everything we can to share accurate, up-to-date information as quickly as possible through our website and social media channels.
We may not receive advance notice of announcements or have all the answers immediately. We will be clear about what has been confirmed, what remains uncertain and where families can find further information.
If you have questions or would like support, you can email info@cureangelman.org.uk Our team will respond as soon as we can, help you find reliable information and signpost you to appropriate support.
For questions about your or your child’s treatment, safety or care within a trial, please contact your trial team directly.